feed,title,long_url,short_url
Benzinga,"With Bumper $33B Sales, Novo Nordisk Forecasts Double-Digit 2024 Earnings Growth, Boosts Lower Dose Wegovy US Supplies",https://benzinga.com/general/biotech/24/01/36865688/with-bumper-33b-sales-novo-nordisk-forecasts-double-digit-2024-earnings-growth-boosts-lower-dose-,https://da.gd/E5NQkC
Benzinga,Troubled Biotech Company's Investigational Cancer Drug Gets Greenlighted By FDA,https://benzinga.com/general/biotech/24/01/36865687/troubled-biotech-companys-investigational-cancer-drug-gets-greenlighted-by-fda,https://da.gd/DzoDk
